OS Therapies, Inc. (OSTX)
1.00
+0.02
(+2.03%)
USD |
NYAM |
Nov 06, 16:00
0.9355
-0.06
(-6.45%)
After-Hours: 20:00
OS Therapies Shareholders Equity (Quarterly) : -10.84M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.84M |
| March 31, 2026 | -9.754M |
| December 31, 2025 | -5.025M |
| September 30, 2025 | 4.708M |
| June 30, 2025 | 6.752M |
| March 31, 2025 | 0.6137M |
| December 31, 2024 | 0.8115M |
| September 30, 2024 | -0.7071M |
| June 30, 2024 | -27.06M |
| March 31, 2024 | -25.51M |
| Date | Value |
|---|---|
| December 31, 2023 | -24.02M |
| September 30, 2023 | -22.52M |
| June 30, 2023 | |
| March 31, 2023 | -18.74M |
| December 31, 2022 | -17.56M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -10.65B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 384.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.897M |
| Total Liabilities (Quarterly) | 20.64M |
| Current Ratio | 0.1764 |